DCGI Allows Usage Of Covishield Vaccine For 9 Months From Manufacture

Drug Controller General of India on March 31 extended the usage time limit of Oxford-AstraZeneca's COVID-19 vaccine Covishield. The vaccine earlier permitted usage for six months after the date of manufacture, can now be used for nine months from its manufacturing date. Writing to the Serum Institute of India, the DCGI stated that all details about the stock should be submitted to DCGI's office and Central Drugs Authority.